Helen Tayton-Martin
Company: Adaptimmune
Job title: Chief Business Officer
Seminars:
Industry Leaders’ Fireside Chat: The Opportunity for Next-Gen 8:40 am
Instilling the importance for innovative platforms and technologies to further enhance cell therapy efficacy Reviewing clinical advances of next generation programmes across solid tumours and autoimmunityRead more
day: Conference Day 1 - AM